Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Łukasz Dembiński, Anna Stelmaszczyk-Emmel, Katarzyna Sznurkowska, Agnieszka Szlagatys-Sidorkiewicz, Andrzej Radzikowski & Aleksandra Banaszkiewicz. (2021) Immunogenicity of cholera vaccination in children with inflammatory bowel disease. Human Vaccines & Immunotherapeutics 17:8, pages 2586-2592.
Read now
Read now
Amit Saha, Alexander Rosewell, Andrew Hayen, C. Raina MacIntyre & Firdausi Qadri. (2017) Improving immunization approaches to cholera. Expert Review of Vaccines 16:3, pages 235-248.
Read now
Read now
Nathalie Böhles, Nathalie Böhles, Kim Busch, Kim Busch, Michael Hensel & Michael Hensel. (2014) Vaccines against human diarrheal pathogens. Human Vaccines & Immunotherapeutics 10:6, pages 1522-1535.
Read now
Read now
Debbie-Ann T Shirley & Monica A McArthur. (2011) The utility of human challenge studies in vaccine development: lessons learned from cholera. Vaccine: Development and Therapy 1, pages 3-13.
Read now
Read now
Articles from other publishers (32)
Natalia Yudintceva, Natalia Mikhailova, Viacheslav Fedorov, Konstantin Samochernych, Tatiana Vinogradova, Alexandr Muraviov & Maxim Shevtsov. (2022) Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice. Bioengineering 9:11, pages 662.
Crossref
Crossref
M. N. Kondratyeva & D. D. Svirina. Artificial intelligence technologies as a competitive advantage of business in the conditions of technological singularity. Artificial intelligence technologies as a competitive advantage of business in the conditions of technological singularity.
John C. Macbeth, Rui Liu, Salma Alavi & Ansel Hsiao. (2021) A dysbiotic gut microbiome suppresses antibody mediated-protection against Vibrio cholerae. iScience 24:12, pages 103443.
Crossref
Crossref
Mahboube Bahroudi, Bita Bakhshi, Sara Soudi & Shahin Najar-peerayeh. (2021) Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate. Stem Cell Research & Therapy 12:1.
Crossref
Crossref
Urs M. Mörbe, Peter B. Jørgensen, Thomas M. Fenton, Nicole von Burg, Lene B. Riis, Jo Spencer & William W. Agace. (2021) Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunology 14:4, pages 793-802.
Crossref
Crossref
Soon Ho Lee, Bo Ram Beck, Seok-Hong Hwang & Seong Kyu Song. (2021) Feeding olive flounder (Paralichthys olivaceus) with Lactococcus lactis BFE920 expressing the fusion antigen of Vibrio OmpK and FlaB provides protection against multiple Vibrio pathogens: A universal vaccine effect. Fish & Shellfish Immunology 114, pages 253-262.
Crossref
Crossref
Ali Karimi Bavandpour, Bita Bakhshi & Shahin Najar-peerayeh. (2020) The roles of mesoporous silica and carbon nanoparticles in antigen stability and intensity of immune response against recombinant subunit B of cholera toxin in a rabbit animal model. International Journal of Pharmaceutics 573, pages 118868.
Crossref
Crossref
Julie C. Caruana & Scott A. Walper. 2020. Bacterial Membrane Vesicles. Bacterial Membrane Vesicles
219
251
.
Emile F.F. Jonker, Marjolein A.C. Uijlings, Leonardus G. Visser & Darius Soonawala. (2019) Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate – A controlled trial. Vaccine 37:23, pages 3133-3139.
Crossref
Crossref
Tamara Reyes-Robles, Rebecca S. Dillard, Lynne S. Cairns, Cecilia A. Silva-Valenzuela, Max Housman, Afsar Ali, Elizabeth R. Wright & Andrew Camilli. (2018) Vibrio cholerae Outer Membrane Vesicles Inhibit Bacteriophage Infection. Journal of Bacteriology 200:15.
Crossref
Crossref
Essam H. Ibrahim, Rasha Asiri & Khalid Al Syaad. (2018) Genetic fusion of tetanus toxin fragment C (Hc) gene to cholera toxin subunit B (CTB) gene as a preparatory step for double vaccine production. Gene Reports 10, pages 90-96.
Crossref
Crossref
Danielle E. Baranova, Kara J. Levinson & Nicholas J. Mantis. (2018) Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination. PLOS ONE 13:1, pages e0190026.
Crossref
Crossref
Caitlyn A. Hauke & Ronald K. Taylor. (2017) Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus. PLOS ONE 12:4, pages e0175170.
Crossref
Crossref
Travis R. McCarthy, Ami A. Patel, Paul E. Anderson & Deborah M. Anderson. 2017. Biological Safety. Biological Safety
163
185
.
Zhu Wang, David W. Lazinski & Andrew Camilli. (2017) Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility. Infection and Immunity 85:1.
Crossref
Crossref
Leslie M. Mayo-Smith, Jakub K. Simon, Wilbur H. Chen, Douglas Haney, Michael Lock, Caroline E. Lyon, Stephen B. Calderwood, Beth D. Kirkpatrick, Mitchell Cohen, Myron M. Levine, Marc Gurwith & Jason B. Harris. (2017) The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae. Clinical and Vaccine Immunology 24:1.
Crossref
Crossref
Yuchen Fan & James J. Moon. (2016) Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens. WIREs Nanomedicine and Nanobiotechnology 9:1.
Crossref
Crossref
Tae Hee Lee, Sun‐Shin Cha, Chang‐Seop Lee, Joon Haeng Rhee, Hye Ryun Woo & Kyung Min Chung. (2016)
Cross‐protection against
Vibrio cholerae
infection by monoclonal antibodies against
Vibrio vulnificus
RtxA1/MARTX
Vv
. Microbiology and Immunology 60:11, pages 793-800.
Crossref
Crossref
Kara J. Levinson, Danielle E. Baranova & Nicholas J. Mantis. (2016) A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes. Vaccine 34:48, pages 5833-5836.
Crossref
Crossref
Kathrin Moor & Emma Slack. (2015) What Makes A Bacterial Oral Vaccine a Strong Inducer of High-Affinity IgA Responses?. Antibodies 4:4, pages 295-313.
Crossref
Crossref
Deborah R. Leitner, Sabine Lichtenegger, Philipp Temel, Franz G. Zingl, Desiree Ratzberger, Sandro Roier, Kristina Schild-Prüfert, Sandra Feichter, Joachim Reidl & Stefan Schild. (2015) A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles. Frontiers in Microbiology 6.
Crossref
Crossref
Kara J. Levinson, Samantha R. Giffen, Michael H. Pauly, Do H. Kim, Ognian Bohorov, Natasha Bohorova, Kevin J. Whaley, Larry Zeitlin & Nicholas J. Mantis. (2015) Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide. Journal of Immunological Methods 422, pages 111-117.
Crossref
Crossref
Kara J. Levinson, Magdia De Jesus & Nicholas J. Mantis. (2015) Rapid Effects of a Protective O-Polysaccharide-Specific Monoclonal IgA on Vibrio cholerae Agglutination, Motility, and Surface Morphology. Infection and Immunity 83:4, pages 1674-1683.
Crossref
Crossref
Shwu-Maan Lee, Vincent Turula, Bradford Powell, Mikkel Nissum, Mariagrazia Pizza, Claudia Magagnoli & Niranjan M. Kumar. 2015. Vaccine Analysis: Strategies, Principles, and Control. Vaccine Analysis: Strategies, Principles, and Control
187
270
.
Deborah R. Leitner, Sandra Feichter, Kristina Schild-Prüfert, Gerald N. Rechberger, Joachim Reidl & Stefan Schild. (2013) Lipopolysaccharide Modifications of a Cholera Vaccine Candidate Based on Outer Membrane Vesicles Reduce Endotoxicity and Reveal the Major Protective Antigen. Infection and Immunity 81:7, pages 2379-2393.
Crossref
Crossref
Gregory A. Price, Kim McFann & Randall K. Holmes. (2013) Immunization with Cholera Toxin B Subunit Induces High-Level Protection in the Suckling Mouse Model of Cholera. PLoS ONE 8:2, pages e57269.
Crossref
Crossref
Lola V StammBenjamin Mudrak. (2013) Old foes, new challenges: syphilis, cholera and TB. Future Microbiology 8:2, pages 177-189.
Crossref
Crossref
Aimee L. Richard & Victor J. DiRita. 2013. The Prokaryotes. The Prokaryotes
125
131
.
Talena Ledón, Beatriz Ferrán, Celso Pérez, Edith Suzarte, Joivier Vichi, Karen Marrero, Reinaldo Oliva & Rafael Fando. (2012) TLP01, an mshA mutant of Vibrio cholerae O139 as vaccine candidate against cholera. Microbes and Infection 14:11, pages 968-978.
Crossref
Crossref
Jessica Queen & Karla J. Fullner Satchell. (2012) Neutrophils Are Essential for Containment of Vibrio cholerae to the Intestine during the Proinflammatory Phase of Infection. Infection and Immunity 80:8, pages 2905-2913.
Crossref
Crossref
Andrew M. SternAmanda J. HayZhi LiuFiona A. DeslandJuan Zhang, Zengtao Zhong & Jun Zhu. (2012) The NorR Regulon Is Critical for Vibrio cholerae Resistance to Nitric Oxide and Sustained Colonization of the Intestines. mBio 3:2.
Crossref
Crossref
Paolo Pasquali. 2012. Innovation in Vaccinology. Innovation in Vaccinology
229
248
.